Europe Epilepsy Devices Market 2022-2028
MARKET OUTLOOK
Triton Market Research’s report indicates that the epilepsy devices market in Europe is anticipated to propel at a compound annual growth rate of 7.94% in revenue during the forecast years 2022-2028. Spain, France, Germany, Italy, the United Kingdom, and the Rest of Europe are evaluated in the region.
In the United Kingdom, patients diagnosed with epilepsy experienced more psychological anguish during the pandemic, leading to high-level seizures. Several young people with epilepsy experienced behavioral and mental health issues. As a result, the aggravation of pre-existing mental health and behavioral disorder is expected to increase the sales of epilepsy monitoring equipment, thereby driving the studied market.
On the other hand, the National Health Services of Italy offer free medical attention to the people. In this regard, people with chronic conditions are entitled to full exemption from paying for medical treatments, diagnostic procedures, etc. During the pandemic, chronic neurological illness lacked medical attention, resulting in high seizure frequency among patients. Therefore, such factors have increased the demand for epilepsy treatments, creating opportunities for the epilepsy devices market across Italy.
COMPETITIVE OUTLOOK
The leading companies in the epilepsy devices market include LivaNova Plc, Natus Medical Incorporated, Cadwell Industries Inc, Medtronic Plc, Koninklijke Philips NV, and Empatica Inc.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook